NCCN Guidelines® Insights: Non-small cell lung cancer, version 2.2023 Guidelines


Authors: Ettinger, D. S.; Wood, D. E.; Aisner, D. L.; Akerley, W.; Bauman, J. R.; Bharat, A.; Bruno, D. S.; Chang, J. Y.; Chirieac, L. R.; DeCamp, M.; Dilling, T. J.; Dowell, J.; Durm, G. A.; Gettinger, S.; Grotz, T. E.; Gubens, M. A.; Hegde, A.; Lackner, R. P.; Lanuti, M.; Lin, J.; Loo, B. W. Jr; Lovly, C. M.; Maldonado, F.; Massarelli, E.; Morgensztern, D.; Ng, T.; Otterson, G. A.; Patel, S. P.; Patil, T.; Polanco, P. M.; Riely, G. J.; Riess, J.; Schild, S. E.; Shapiro, T. A.; Singh, A. P.; Stevenson, J.; Tam, A.; Tanvetyanon, T.; Yanagawa, J.; Yang, S. C.; Yau, E.; Gregory, K. M.; Hughes, M.
Title: NCCN Guidelines® Insights: Non-small cell lung cancer, version 2.2023
Abstract: The NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) provide recommendations for management of disease in patients with NSCLC. These NCCN Guidelines Insights focus on neoadjuvant and adjuvant (also known as perioperative) systemic therapy options for eligible patients with resectable NSCLC.
Keywords: neoadjuvant therapy; carcinoma, non-small-cell lung; lung neoplasms; lung tumor; non small cell lung cancer; humans; human
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 21
Issue: 4
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2023-04-01
Start Page: 340
End Page: 350
Language: English
DOI: 10.6004/jnccn.2023.0020
PUBMED: 37015337
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 1 May 2023 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gregory J Riely
    599 Riely
Related MSK Work